Inflammatory Bowel Disease: Diagnosis and TreatmentGary L. Gitnick |
From inside the book
Results 1-3 of 70
Page 271
... dose . However , if a patient tolerates a dose of 4 grams per day but has not responded there is no reason to refrain from pushing the dosage higher . To lessen the side effects , sulfasalazine is given in gradually increasing doses ...
... dose . However , if a patient tolerates a dose of 4 grams per day but has not responded there is no reason to refrain from pushing the dosage higher . To lessen the side effects , sulfasalazine is given in gradually increasing doses ...
Page 286
... doses of 2 or 4 g had a more rapid response clinically , sigmoidoscopically , and histologically than those receiving placebo or 1 - g dose of Pentasa . The 4 - g dosage showed some overall benefit as compared with the 2 g dosage ...
... doses of 2 or 4 g had a more rapid response clinically , sigmoidoscopically , and histologically than those receiving placebo or 1 - g dose of Pentasa . The 4 - g dosage showed some overall benefit as compared with the 2 g dosage ...
Page 349
... DOSAGE 5 When we first tried metronidazole in the treatment of Crohn's disease in 1975 , the dose chosen was high . We gave a daily dose of 2400 mg , which is about 40 mg per kg . Although clinical results were promising , the patients ...
... DOSAGE 5 When we first tried metronidazole in the treatment of Crohn's disease in 1975 , the dose chosen was high . We gave a daily dose of 2400 mg , which is about 40 mg per kg . Although clinical results were promising , the patients ...
Contents
Approaches to Management | 3 |
Epidemiology | 23 |
Where Have We Been? Where Are We Going? | 29 |
Copyright | |
32 other sections not shown
Other editions - View all
Common terms and phrases
5-aminosalicylic acid abdominal abnormalities abscess acute anal anastomosis ankylosing spondylitis antibiotics antigens arthritis associated azathioprine barium biopsies cancer carcinoma cells chronic clinical colectomy colitis and Crohn's colon colonoscopy complications controlled trial corticosteroids Crohn's colitis Crohn's disease diagnosis diarrhea diet dilatation disease activity disease and ulcerative distal dosage dose drug dysplasia endoscopic enemas epithelial evaluation factors fistulas Gastroenterology genetic histologic hydrocortisone IBD patients ileal ileoanal ileostomy ileum immunosuppressive improved increased inflammation inflammatory bowel disease intestinal intravenous involvement Lancet Lennard-Jones lesions manifestations methotrexate metronidazole mucosa normal obstruction occur oral parenteral nutrition patients with Crohn's patients with ulcerative perianal physician placebo pouch procedure prednisolone prednisone present proctitis prognosis rectal rectum recurrence relapse remission reported resection response risk serum side effects sigmoidoscopic small bowel steroids stool strictures sulfasalazine Surg surgery surgical symptoms therapeutic therapy tion tissue toxic megacolon treated Truelove ulcerative colitis usually